Skip to main content
Veterinary Medicines

Rafendazol, 10+8mg/g, Perorální prášek

Authorised
  • Rafoxanide
  • Mebendazole

Product identification

Medicine name:
Rafendazol, 10+8mg/g, Perorální prášek
Active substance:
  • Rafoxanide
  • Mebendazole
Target species:
  • Fallow deer
  • Deer
  • Chamois
  • Mouflon
  • Roe deer
Route of administration:
  • In-feed use

Product details

Active substance and strength:
  • Rafoxanide
    10.00
    milligram(s)
    /
    1.00
    gram(s)
  • Mebendazole
    8.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • In-feed use
    • Fallow deer
      • Meat and offal
        28
        day
    • Deer
      • Meat and offal
        28
        day
    • Chamois
      • Meat and offal
        60
        day
    • Mouflon
      • Meat and offal
        60
        day
    • Roe deer
      • Meat and offal
        28
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC59
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • BIOPHARM Vyzkumny ustav biofarmacie a veterinarnich leciv a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biopharm Research Institute Of Biopharmacy And Veterinary Drugs a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 96/131/04-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."